Clinical Trial Update: Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Maridebart Cafraglutide for obesity in adults without type 2 diabetes is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Maridebart Cafraglutide

Snippet

Sponsor: Amgen | Conditions: Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING